Correlation Between Cabio Biotech and Spero Therapeutics
Specify exactly 2 symbols:
By analyzing existing cross correlation between Cabio Biotech Wuhan and Spero Therapeutics, you can compare the effects of market volatilities on Cabio Biotech and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cabio Biotech with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cabio Biotech and Spero Therapeutics.
Diversification Opportunities for Cabio Biotech and Spero Therapeutics
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cabio and Spero is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Cabio Biotech Wuhan and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Cabio Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cabio Biotech Wuhan are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Cabio Biotech i.e., Cabio Biotech and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Cabio Biotech and Spero Therapeutics
Assuming the 90 days trading horizon Cabio Biotech Wuhan is expected to under-perform the Spero Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cabio Biotech Wuhan is 2.01 times less risky than Spero Therapeutics. The stock trades about -0.17 of its potential returns per unit of risk. The Spero Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 194.00 in Spero Therapeutics on September 10, 2025 and sell it today you would earn a total of 37.00 from holding Spero Therapeutics or generate 19.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 92.06% |
| Values | Daily Returns |
Cabio Biotech Wuhan vs. Spero Therapeutics
Performance |
| Timeline |
| Cabio Biotech Wuhan |
| Spero Therapeutics |
Cabio Biotech and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cabio Biotech and Spero Therapeutics
The main advantage of trading using opposite Cabio Biotech and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cabio Biotech position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.| Cabio Biotech vs. 159681 | Cabio Biotech vs. 159005 | Cabio Biotech vs. Loctek Ergonomic Technology | Cabio Biotech vs. Yes Optoelectronics Co |
| Spero Therapeutics vs. Seres Therapeutics | Spero Therapeutics vs. VistaGen Therapeutics | Spero Therapeutics vs. Actuate Therapeutics, Common | Spero Therapeutics vs. Inovio Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |